SCHEMBL1447170

SCHEMBL1447170

CCCCCCCCCCCCCCCCCC(=O)OC=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.58
DGKA P23743 1/20 0.57
LMNA P02545 2/20 0.53
PAM P19021 2/20 0.52
CES2 O00748 3/20 0.50
CES1 P23141 3/20 0.50
MAPT P10636 2/20 0.50
MAPK1 P28482 1/20 0.50
PPARG P37231 6/20 0.48
PPARD Q03181 6/20 0.48
PPARA Q07869 6/20 0.48
HDAC11 Q96DB2 5/20 0.48
GPR84 Q9NQS5 4/20 0.48
ALDH1A1 P00352 2/20 0.48
TLR2 O60603 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
FABP4 P15090 2/20 0.48
PTPN1 P18031 2/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28140931 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL1548895 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL9152744 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL594731 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL1356043 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL1903671 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL4398855 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL11740813 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL9421274 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2
SCHEMBL7524821 1.00 TSHR (0.58) TSHRDGKALMNAPAMCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101132776-A Stable tablet formulation of tetrahydrobiopterin BIOMARIN PHARM INC (US) 2008-02-27 CN claimed
US-20070270581-A1 Stable Tablet Formulation BIOMARIN PHARMACEUTICAL INC. (US) 2007-11-22 US claimed
EP-1845952-A2 STABLE TABLET FORMULATION OF TETRAHYDROBIOPTERIN Biomarin Pharmaceutical Inc. (US) 2007-10-24 EP claimed
WO-2006055511-A2 STABLE TABLET FORMULATION OF TETRAHYDROBIOPTERIN BIOMARIN PHARMACEUTICAL INC. (US) 2006-05-26 WO claimed
US-5434276-A Process for making N-acyl taurides FINETEX, INC. (US) 1995-07-18 US claimed
EP-0062362-B1 STABILIZERS FOR VINYL HALIDE POLYMERS FERRO CORPORATION (US) 1985-07-24 EP claimed
CN-112159498-B Fly ash water-based slurry for ceramic 3D printing and preparation method thereof 武汉因泰莱激光科技有限公司 2023-04-21 CN disclosed
CN-113751295-B Preparation method and application of durable, super-smooth and super-hydrophobic surface 浙江大学 2022-07-08 CN disclosed
CN-110117510-B Grease composition, clutch and electric window motor NOK克鲁勃株式会社 2022-03-25 CN disclosed
CN-113751295-A Preparation method and application of durable, super-smooth and super-hydrophobic surface 浙江大学 2021-12-07 CN disclosed
CN-107406792-B Grease composition NOK克鲁伯有限公司 2021-03-09 CN disclosed
CN-106573304-B Silver powder and method for producing same 同和电子科技有限公司 2020-03-03 CN disclosed
US-10170213-B2 Silver powder and method for producing same DOWA ELECTRONICS MATERIALS CO., LTD. (JP) 2019-01-01 US disclosed
EP-0017503-A2 Gem-bis (hydroxymethyl) alcohols and mixtures thereof with diols, process for their preparation and a process for the preparation of polyurethanes therefrom HENKEL CORPORATION (a Delaware corp.) (US) 1980-10-15 EP disclosed
US-4222914-A ZINC NEUTRALIZED EXXON RESEARCH & ENGINEERING CO. (US) 1980-09-16 US disclosed
US-4216344-A High molecular weight polyol mixtures HENKEL CORPORATION (US) 1980-08-05 US disclosed
US-4216343-A High molecular weight polyhydric alcohols HENKEL CORPORATION (US) 1980-08-05 US disclosed
EP-0002358-A2 Process for forming a zinc neutralised sulphonated elastomeric polymer and composition thereof EXXON RESEARCH AND ENGINEERING COMPANY (US) 1979-06-13 EP disclosed
US-4083816-A Acetoxymethyl derivatives of polyunsaturated fatty triglycerides as primary plasticizers for polyvinylchloride THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 1978-04-11 US disclosed
US-4066585-A THERMOPLASTIC BINDERS SCHERING AKTIENGESELLSCHAFT (DT) 1978-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270581-A1 Stable Tablet Formulation QDPR, ADCYAP1R1, TPH1 TSHR 1498/4885DGKA 4679/4885LMNA 3651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.